2025-10-03 - Analysis Report
Okay, here's an analysis of Linde PLC (LIN) based on the data provided, presented in a format suitable for a report.

**Linde PLC (LIN) Analysis**

**Company Overview:** Linde PLC is a leading global industrial gases and engineering company.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (LIN):** 82.24%
*   **Cumulative Return (VOO):** 97.56%
*   **Return Difference:** -15.3%
*   **Relative Deviation:** 0.7

**Analysis:** Linde has underperformed the S&P 500 based on cumulative returns. The current deviation of -15.3% indicates underperformance relative to the benchmark. The relative deviation of 0.7 suggests that the underperformance is near the lower end of its historical range, meaning it has rarely been this far behind the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha  | Beta | Cap(B) |
| ---------- | ----- | ----- | ------ | ---- | ------ |
| 2015-2017  | 36.0% | 9.2%  | 8.0%   | 0.0  | 72.5   |
| 2016-2018  | 27.0% | 69.9% | 12.0%  | 0.2  | 73.2   |
| 2017-2019  | 41.0% | 69.9% | 19.0%  | 0.4  | 99.8   |
| 2018-2020  | 14.0% | 78.6% | -10.0% | 0.4  | 123.6  |
| 2019-2021  | 63.0% | 78.6% | 16.0%  | 0.9  | 162.5  |
| 2020-2022  | 37.0% | 78.6% | 38.0%  | 0.8  | 153.0  |
| 2021-2023  | 43.0% | 76.7% | 41.0%  | 0.5  | 192.6  |
| 2022-2024  | 6.0%  | 76.7% | -14.0% | 0.5  | 196.3  |
| 2023-2025  | 9.0%  | 79.5% | -53.0% | 0.5  | 223.5  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  Fluctuates significantly, showing periods of strong growth (e.g., 2019-2021) and weaker performance (e.g., 2022-2024, 2023-2025).
*   **MDD (Maximum Drawdown):**  Relatively high drawdown figures, especially in recent periods, indicating significant potential for losses.
*   **Alpha:** Varies considerably.  Positive alpha indicates outperformance relative to the benchmark, while negative alpha suggests underperformance. Recent periods (2022-2025) show significant negative alpha, contributing to the underperformance vs. VOO.
*   **Beta:** Generally below 1, suggesting lower volatility than the overall market. The beta has been fluctuating between 0 and 0.9 over the years.
*   **Cap(B):**  Market capitalization has steadily increased over the period, showing consistent growth in the company's overall value, despite fluctuations in performance metrics.

**2. Recent Stock Price Movement**

*   **Current Price:** 476.51
*   **Last Market Data:** Price = 469.48, Previous Close = 466.81, Change = 0.57
*   **5-Day Moving Average:** 475.754
*   **20-Day Moving Average:** 475.626
*   **60-Day Moving Average:** 473.2182

**Analysis:** The current price is slightly above the 5-day, 20-day, and 60-day moving averages, suggesting a potential short-term upward trend.  The `change` value of 0.57 from the last market indicates a small upward movement since the previous close.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 52.99 (Neutral)
*   **PPO:** -0.08 (Slightly Bearish)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1 shares - Very Safe - MRI:0.90)
*   **Recent (20-day) Relative Deviation Change:** 0.7 (+): Short-term increase
*   **Expected Return:** 3347.9% (Long-term, vs. S&P 500)

**Analysis:**

*   The **MRI** suggests that, based on its methodology, the stock is considered a "High Investment Recommended" asset.
*   The **RSI** is near the neutral level, indicating neither overbought nor oversold conditions.
*   The **PPO** is slightly negative, which is a marginally bearish signal.
*   The **Hybrid Signal** recommendation is to invest all available cash, suggesting a bullish outlook despite some mixed signals from other indicators.
*   The recent increase in relative deviation suggests a recent uptick in performance relative to the S&P 500, although it remains behind overall.
*   The extremely high **Expected Return** should be treated with caution. Such a high projection is likely based on specific models and assumptions and might not be realistic.  It suggests potential for significant outperformance over the long term (2+ years) if the model's assumptions hold true.
*   The `change` value of 0.57, while positive, is not large enough to indicate a significant volatility event ( 급반등, 급하락).

**4. Recent News & Significant Events**

*   **[2025-10-02] Linde (LIN): A Fresh Valuation Check After Recent Share Price Pause:** This suggests analysts are reassessing the stock's value after a period of price stability.
*   **[2025-10-01] Linde Names CEO Sanjiv Lamba as Chairman, Succeeds Retiring Steve Angel; Appoints Sean Durbin as COO:** This is significant leadership change news. It could be a catalyst for future strategic shifts and operational adjustments.
*   **[2025-09-29] Linde Appoints Sanjiv Lamba as Chairman & CEO:** Confirms the leadership transition.

**Analysis:** The recent news highlights a leadership transition, which is a critical factor to consider. New leadership can bring new strategies and impact the company's future performance.  The "Valuation Check" article also suggests potential uncertainty or a need for reassessment in the market's view of the stock.

**4-2. Analyst Opinions**

*   **Consensus:** Buy
*   **Mean Rating:** 1.72 (Buy)
*   **Opinions:** 22
*   **Target Price:** 513.05 / 576.00 / 381.00 (Avg/High/Low)

**Analysis:** The analyst consensus is positive, with a "Buy" rating and a mean rating of 1.72. The average target price of 513.05 suggests potential upside from the current price.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출     |
| ---------- | ---- | -------- |
| 2025-08-01 | 3.75 | 8.49 B$  |
| 2025-05-01 | 3.53 | 8.11 B$  |
| 2024-10-31 | 3.24 | 8.36 B$  |
| 2024-08-02 | 3.46 | 8.27 B$  |
| 2025-08-01 | 3.46 | 8.27 B$  |

**Analysis:**

*   **EPS (Earnings Per Share):** Shows an upward trend, indicating increasing profitability.  The EPS has generally increased over the reported quarters.
*   **Revenue:**  Remains relatively stable, fluctuating between $8.11B and $8.49B.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
| ---------- | ---------- | ------------- |
| 2025-06-30 | $8.49B    | 49.31%        |
| 2025-03-31 | $8.11B    | 48.75%        |
| 2024-12-31 | $8.28B    | 47.84%        |
| 2024-09-30 | $8.36B    | 47.87%        |
| 2024-06-30 | $8.27B    | 48.58%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE     |
| ---------- | ---------- | ------- |
| 2025-06-30 | $38.52B   | 4.59%   |
| 2025-03-31 | $38.03B   | 4.40%   |
| 2024-12-31 | $38.09B   | 4.53%   |
| 2024-09-30 | $39.17B   | 3.96%   |
| 2024-06-30 | $38.18B   | 4.36%   |

**Analysis:**

*   **Revenue & Profitability:**  Revenue is generally stable, with a slight increase in the most recent quarter. Profit margins are healthy and stable, indicating good operational efficiency.
*   **Capital & Profitability:**  Equity is stable. ROE (Return on Equity) shows some fluctuation but remains in a reasonable range.

**7. 종합 Analysis**

Linde PLC (LIN) presents a mixed picture. While the company demonstrates strong fundamentals, including stable revenue, healthy profit margins, and a positive analyst consensus, it has recently underperformed the S&P 500. The leadership transition is a key factor to watch.

**Key Positives:**

*   Strong fundamentals: Stable revenue, healthy profit margins, increasing EPS.
*   Positive analyst consensus with potential upside.
*   High Market Risk Indicator suggests it's a good time to invest, according to that metric.
*   Hybrid signal to Buy all available cash

**Key Concerns:**

*   Recent underperformance compared to the S&P 500, as reflected in the negative return difference and recent negative Alpha.
*   High Maximum Drawdown in recent periods.
*   Leadership transition introduces uncertainty.

**Overall:**

Linde is a fundamentally sound company in a stable industry. The recent underperformance and leadership change warrant close monitoring. The analyst consensus and high MRI suggest potential upside, but investors should be aware of the risks associated with the recent underperformance and leadership transition. The extremely high expected return should be viewed skeptically.

